ImmunityBio (IBRX)
8.08
-0.11 (1.34%)
Upcoming Events
Latest Headlines
Piper Sandler on Biotechnology: 'Look for Biotech to Outperform through YE:26'
September 1, 2026 9:07 AM - StreetInsider
ImmunityBio names former World Bank president Jim Yong Kim as vice chairman
August 10, 2026 9:01 AM - StreetInsider
ImmunityBio Appoints Dr. Jim Yong Kim, Former World Bank President and Global Health Leader, as Vice Chairman
August 10, 2026 9:00 AM - BizWire
Form SCHEDULE 13D/A ImmunityBio, Inc. Filed by: Cambridge Equities, LP
August 6, 2026 6:51 PM - SEC Filing
Form 10-Q ImmunityBio, Inc. For: Jun 30
August 4, 2026 7:46 AM - SEC Filing
ImmunityBio, Inc. (IBRX) Misses Q2 EPS by 14c
August 4, 2026 7:38 AM - StreetInsider
Form 8-K ImmunityBio, Inc. For: Aug 04
August 4, 2026 7:36 AM - SEC Filing
ImmunityBio Reports Record Q2 2026 Net Product Revenue of $50.7 Million, Up 92% Year-Over-Year; First-Half Revenue Up 121% to $94.8 Million
August 4, 2026 7:30 AM - BizWire
Form 8-K ImmunityBio, Inc. For: Jul 29
July 30, 2026 5:20 PM - SEC Filing
UAE approves ImmunityBio's Anktiva for bladder and lung cancer
July 30, 2026 4:53 AM - StreetInsider
ImmunityBio Receives United Arab Emirates (UAE) Marketing Authorization for ANKTIVA® Across BCG-Unresponsive Non-Muscle Invasive Bladder Cancer for CIS and Papillary Disease and Metastatic Non-Small
July 29, 2026 6:45 PM - BizWire
Form 4 ImmunityBio, Inc. For: Jul 02 Filed by: Cohen Cheryl
July 6, 2026 8:26 PM - SEC Filing
Form 4 ImmunityBio, Inc. For: Jul 01 Filed by: Selecky Christobel
July 6, 2026 8:26 PM - SEC Filing
Form 144 ImmunityBio, Inc. Filed by: Cohen Cheryl
July 2, 2026 4:33 PM - SEC Filing
Form 4 ImmunityBio, Inc. For: Jun 29 Filed by: Selecky Christobel
July 1, 2026 5:05 PM - SEC Filing
Form 144 ImmunityBio, Inc. Filed by: Selecky Christobel
July 1, 2026 4:30 PM - SEC Filing
Form 144 ImmunityBio, Inc. Filed by: Selecky Christobel
June 30, 2026 4:36 PM - SEC Filing
Form 144 ImmunityBio, Inc. Filed by: Selecky Christobel
June 29, 2026 4:44 PM - SEC Filing
Form 4 ImmunityBio, Inc. For: Jun 24 Filed by: Simon Barry J.
June 26, 2026 9:02 PM - SEC Filing
Form 4 ImmunityBio, Inc. For: Jun 09 Filed by: BLASZYK MICHAEL D
June 10, 2026 8:12 PM - SEC Filing
Form 4 ImmunityBio, Inc. For: Jun 09 Filed by: Wendel Bruce
June 10, 2026 8:12 PM - SEC Filing
Form 4 ImmunityBio, Inc. For: Jun 09 Filed by: MAXWELL LINDA
June 10, 2026 8:12 PM - SEC Filing
Form 4 ImmunityBio, Inc. For: Jun 09 Filed by: Clark Wesley
June 10, 2026 8:11 PM - SEC Filing
Form 4 ImmunityBio, Inc. For: Jun 09 Filed by: Cohen Cheryl
June 10, 2026 8:11 PM - SEC Filing
Form 4 ImmunityBio, Inc. For: Jun 09 Filed by: Selecky Christobel
June 10, 2026 8:11 PM - SEC Filing
Form 8-K ImmunityBio, Inc. For: Jun 09
June 10, 2026 5:24 PM - SEC Filing
Three Cancer Drugs Have Reached the Clinic: Inside GT Biopharma's TriKE Bet
June 8, 2026 9:01 AM - Globe NewsWire
Three Cancer Drugs Have Reached the Clinic: Inside GT Biopharma's TriKE Bet
June 8, 2026 9:01 AM - StreetInsider
Full Article List